Kodak's Q4 2024 revenue decreased by 3% year-over-year to $266 million, but the company achieved a substantial improvement in profitability. Net income surged to $26 million from $5 million, while operational EBITDA rose from $2 million to $9 million. The gross profit margin expanded to 19%, reflecting cost optimizations. Kodak remains focused on growth initiatives, including its pharmaceutical manufacturing expansion and digital print innovations.
Revenue declined 3% year-over-year to $266 million in Q4 2024.
Net income increased significantly to $26 million, up from $5 million in Q4 2023.
Operational EBITDA surged to $9 million, marking a 350% increase.
Gross profit margin improved to 19%, reflecting operational efficiencies.
Kodak expects continued investments in growth initiatives, particularly in its pharmaceutical and digital print businesses, with an emphasis on improving profitability.